1.. INTRODUCTION
================

At the global level, the prevalence of type 2 diabetes has dramatically increased ([@ref1]-[@ref3]). Research has shown a significant relationship between diabetes and each of obesity and insulin resistance as well as alterations in the function of β-cells in the pancreas ([@ref4], [@ref5]). The resulting influences include declining rates of insulin metabolism such as glucose, lipids, and proteins ([@ref3], [@ref6]). Diabetes can result in regulatory alterations in the hemostasis of calcium, phosphorus and magnesium ending with serious complications including cardiovascular disease and neurological disorders ([@ref7], [@ref8]). According to the American Diabetes Association (ADA), pre-diabetes can be defined as either impairment of fasting glucose (5.6--6.9 mmol/L) or impairment of oral glucose tolerance test (2-h OGTT glucose 7.8--11.0 mmol/L) ([@ref9]). Other studies showed that the pre-diabetic state is characterized by a reduction of glucose tolerance and delayed insulin secretion ([@ref10]).

It has been demonstrated that the state of pre-diabetes is associated with developing cardiovascular events such as myocardial abnormalities. Accordingly, as early as the cardiac changes have been determined in this state, the results are optimal in preventing the development of heart diseases ([@ref11]).

Various animal models to study diabetes have been described in the literature including the high-fat diet/streptozotocin treated (HFD/STZ) rat model. In this model, there is a combination of a fatty diet and STZ ([@ref12], [@ref13]). One of the well- studied models is the male Zucker Diabetic Fatty (ZDF) rat that exhibits intolerance of glucose, insulin resistance, and hyperlipidemia. Depending on a fatty diet (6.5% fat content), rats can develop diabetes within 8 weeks of age ([@ref14]).

Medical herbs have been used to treat human diseases including diabetes and other diseases since ancient times ([@ref15], [@ref16]). Dina et al ([@ref17]) evaluated the extract of *Urtica pilulifera* in treating diabetic rat models. Researchers showed that there was a significant reduction in glucose levels.

2.. AIM
=======

The main objectives of the present study were to investigate the potential of using *Urtica pilulifera* in treating the pre-diabetic rat model and to investigate its anti-oxidant impact.

3.. MATERIAL AND METHODS
========================

Induction of pre-diabetic rat model
-----------------------------------

Male adult (16 weeks-old) Wistar rats (Yarmouk University, Animal house Unit, Jordan) were chosen for this study. The average of rat weight was (196±7.25 g). For the acclimatization process, animals were kept under optimal conditions including environment with controlled temperature (22--23°C) and light-dark cycle for 1week. Then, animals were randomly divided into three groups (n=10). The first group, the control group (n=10), the second group, the pre-diabetic group (n=10) and the third group, treated group with extract of *U. pilulifera* (n=10). The control group received tap water and a standard diet. Pre-diabetic received tap water for drinking in addition to high sucrose diet (HSu) (35% sucrose). We followed the methodology in preparing the pre-diabetic model as described by the study of Nunes et al ([@ref11]). The treated group received the same treatment as the pre-diabetic group, but treated with an intraperitoneal injection of 1.25 mg/kg of body weight daily. The extraction of *U. pilulifera* leaves was made as described by previous studies ([@ref18]). After the end of the study, blood samples were withdrawn into blood tubes (red tubes) to collect serum.

Assessment of the following tests was made in private clinical laboratories: glucose level, lipid profile (cholesterol and triglyceride), and antioxidants (GSH, TAC, and MDA).

4.. RESULTS
===========

Glucose and lipid profile levels in study groups
------------------------------------------------

As seen in ([Table 1](#table1){ref-type="table"} and [Figure 1](#figure1){ref-type="fig"}), the mean level of glucose in the control group is 98±7.5 mg/dl. Pre-diabetic conditions significantly increased the mean level of glucose to 125±15.8 mg/dl (p\<0.001). Treatment with the extract of *U. pilulifera* significantly decreased the level of glucose from 125.15.8 mg/dl to 108±12.45 mg/dl (p\<0.001). The mean levels of cholesterol were not significantly changed between study groups. On the other hand, the mean levels of triglycerides were significantly increased from 65.23±9.96 mg/dl in the control group to 115.19±16.18 in the pre-diabetic group (p\<0.001). Treatment with the extract of *U. pilulifera* significantly decreased the mean level of cholesterol from 115.19±16.18 mg/dl in the pre-diabetic group to 95±14.43 mg/dl in the treated group (p\<0.001).

The mean levels of antioxidants in study groups
-----------------------------------------------

As demonstrated in ([Table 2](#table2){ref-type="table"}, and [Figure 2](#figure2){ref-type="fig"}), the mean level of GSH was 0.32±0.052 nmol/ml. pre-diabetic conditions significantly decreased the levels of GSH into 0.15±0.026 (p\<0.001). The treatment using the extract of *U. pilulifera* significantly increased the levels of GSH (0.22±0.031) (p\<0.001). For TAC, no significant changes were observed between the control group and the pre-diabetic group. There were significantly increased levels of TAC in the treated group compared with the pre-diabetic group (p\<0.001). The levels of MDA were significantly increased in the pre-diabetic group compared with the control group (p\<0.001). The treatment with the extract of *U. pilulifera* significantly reduced the level of MDA in the treated group compared with the pre-diabetic group (p\<0.001).

5.. DISCUSSION
==============

Diabetes has already been studied extensively in the literature, particularly in animal models including rats ([@ref3], [@ref17], and [@ref18]). Little studies have been conducted on pre-diabetes, particularly the high sucrose model ([@ref11]). Pre-diabetes is the early area preceding the development of type 2 diabetes ([@ref19]).

The findings of the present study showed that pre-diabetic conditions increased significantly the levels of glucose (p\<0.001). This was associated with significantly increased levels of triglycerides (p\<0.001). The mean level of cholesterol was not significantly changed in study groups. It is plausible to consider that increased levels of triglycerides are associated with the development of the pre-diabetic conditions and may be involved in developing other conditions like cardiovascular diseases at this stage ([@ref11], [@ref20]). Treatment with the extraction of *U. pilulifera* was interestingly found to significantly decrease the levels of both glucose and triglycerides compared with pre-diabetic group. Previous studies demonstrated beneficial effects against diabetes by *U. pilulifera* ([@ref15]), but its use in pre-diabetic conditions may not be indicated up to the best knowledge of the author.

We studied the effects of pre-diabetic conditions on some anti-oxidants. Pre-diabetic conditions increased the levels of glutathione reduced (GSH) significantly compared with the control group. The accumulation of GSH has damaging effects and participates in the formation of oxidative conditions such as reactive oxygen species and reactive nitrogen species ([@ref21]). Treatment with *U. pilulifera* significantly decreased the levels of GSH. From the study results, it is obvious that the treatment of *U. pilulifera* helps in reducing glucose levels and oxidative stress ([@ref15], [@ref18], and [@ref22]). The study findings showed that the levels of total anti-oxidant capacity (TAC) were similar in both, the control group and pre-diabetic group, but the treatment with *U. pilulifera* significantly increased the levels TAC. TAC acts to protect against free radicals and as a result combat the oxidative effect. Although its level was not significantly increased in the pre-diabetic group, the use of *U. pilulifera* significantly increased the levels of TAC. In general, the importance of TAC to reduce the effects of oxidative stress was indicated in previous studies ([@ref23]).

The levels of malate dehydrogenase (MDA) were significantly increased in the pre-diabetic group compared with the control group, whereas the levels of MDA were significantly decreased because of the effect of treatment with *U. pilulifera*. Other studies reported that MDA to be higher in diabetic patients ([@ref24]). Previous studies pointed out to MDA as one of the products resulting from lipid peroxidation ([@ref25]-[@ref27]).

6.. CONCLUSION
==============

The results of this study showed that pre-diabetic model based on high sucrose diet can be further used in other studies to better understand diabetes from one side, and from the other side, the use of treatment with *U. pilulifera* is beneficial in controlling glycemia, lowering lipid profile, and acting against oxidative stress mechanisms.
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###### Glucose and lipid levels in study groups. Values are expressed as means± SD. \*pre-diabetic group is compared with control group, \*\*treated group is compared with pre-diabetic group.

  Variable                Control group   Pre-diabetic group   Treated group
  ----------------------- --------------- -------------------- ---------------
  Glucose (mg/dl)         98±7.5          125±15.8\*           108±12.45\*\*
  Cholesterol (mg/dl)     61.45 ± 0.85    54.53 ± 3.44         51.21±2.32
  Triglycerides (mg/dl)   65.23 ± 9.96    115.19 ± 16.18\*     95 ±14.43\*\*

###### The mean levels of antioxidants in study groups. Values are expressed as means± SD. \*pre-diabetic group is compared with control group, \*\*treated group is compared with pre-diabetic group.

  Variable         Control group   Pre-diabetic group   Treated group
  ---------------- --------------- -------------------- ----------------
  GSH (nmol/ ml)   0.32±0.052      0.15±0.026\*         0.22±0.031\*\*
  TAC (nmol/μl)    1.9 ± 0.15      1.6±0.18             2.8±0.19\*\*
  MDA (nmol/μl)    0.07 ± 0.1      0.25±0.12\*          0.13±0.10\*\*
